Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens-Reference-Cited by-同舟云学术

Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens

Published:2020-03-05 Issue:3 Volume:15 Page:e0229873
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Karvaly Gellért Balázs^ORCID,Neely Michael N.,Kovács Krisztián,Vincze István^ORCID,Vásárhelyi Barna,Jelliffe Roger W.

Funder

Hungarian Scientific Research Fund

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Role of statistical random-effects linear models in personalized medicine;FJ Diaz;Curr Pharmacogenom Pers Med,2012

2. Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy;IB Bondareva;J Clin Pharm Ther,2011

3. Individualized antibiotic dosing for patients who are critically ill: challenges and potential solutions;JA Roberts;Lancet Infect Dis,2014

4. Software for dosage individualization of voriconazole for immunocompromised patients;WW Hope;Antimicrob Agents Chemother,2013

5. Least-squares fitting with errors in the response and predictors;T Burr;Int J Metrol Qual Eng,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin;Pharmaceutics;2024-03-04

2. A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib;Molecules;2022-07-25

3. Assessment of Antibiotic Pharmacokinetics, Molecular Biomarkers and Clinical Status in Critically Ill Adults Diagnosed with Community-Acquired Pneumonia and Receiving Intravenous Piperacillin/Tazobactam and Hydrocortisone over the First Five Days of Intensive Care: An Observational Study (STROBE Compliant);Journal of Clinical Medicine;2022-07-16

4. Review of the Preanalytical Errors That Impact Therapeutic Drug Monitoring;Therapeutic Drug Monitoring;2021-10

5. A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy;Pharmacology Research & Perspectives;2021-09-03